Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-03 · accession 0001159036-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-03 | HALO | Snyder Mark Howard | SVP, CLO | F - Tax | $70.31 | -4,243 | 34.2K | -11% | -$298.3K |
| D | 2026-01-06 | 2026-01-03 | HALO | Snyder Mark Howard | SVP, CLO | M - OptEx | $0.00 | +7,611 | 38.4K | +25% | $0 |
| D | 2026-01-06 | 2026-01-03 | HALO | Snyder Mark Howard | SVP, CLO | M - OptEx | $0.00 | -7,611 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-03 | F | D | 4,243 | $70.31 | 34,181 | D | — | — | (F1) The reported disposition of 4,243 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 2 | Common | Common Stock | 2026-01-03 | M | A | 7,611 | $0.00 | 38,424 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-01-03 | M | D | 7,611 | $0.00 | 0 | D | $0.00 · — to — | 7,611 Common Stock | (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |